Allergy Therapeutics plc (LON:AGY – Get Free Report)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as GBX 6.50 ($0.08) and last traded at GBX 6.40 ($0.08), with a volume of 91787 shares changing hands. The stock had previously closed at GBX 6.40 ($0.08).
Allergy Therapeutics Trading Down 3.1 %
The company has a debt-to-equity ratio of 37.22, a quick ratio of 1.48 and a current ratio of 1.40. The business’s 50-day moving average price is GBX 5.30 and its 200 day moving average price is GBX 4.98. The company has a market cap of £295.74 million, a P/E ratio of -103.33, a P/E/G ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
Featured Articles
- Five stocks we like better than Allergy Therapeutics
- Want to Profit on the Downtrend? Downtrends, Explained.
- Micron Stock Under $100: Seize the AI-Driven Upside
- Roth IRA Calculator: Calculate Your Potential Returns
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Comparing and Trading High PE Ratio Stocks
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
